Stay updated on Filgotinib Long-Term Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Long-Term Ulcerative Colitis Clinical Trial page.

Latest updates to the Filgotinib Long-Term Ulcerative Colitis Clinical Trial page
- Check7 days agoChange DetectedRevision v3.5.5 is now shown on the page footer. This indicates a new revision tag for the study record without altering substantive content or functionality.SummaryDifference0.0%

- Check14 days agoChange DetectedLocations now includes Pisa, Italy (56124) as a new study site, expanding recruitment options in Italy. The previous Pisa entry has been removed.SummaryDifference0.2%

- Check21 days agoChange DetectedLakefront Biotherapeutics NV is added as a collaborator and Galapagos NV is removed as a collaborator. The page revision is updated from v3.5.3 to v3.5.4 to capture these changes.SummaryDifference0.0%

- Check29 days agoNo Change Detected
- Check36 days agoChange Detected- Added Malmö, Sweden, SE-205-02 and Taoyuan, Taiwan, 33305 to the study location list. - Removed Malmo, Sweden, SE-205-02 and Taoyuan District, Taiwan, 33305 to replace with standardized site identifiers.SummaryDifference0.0%

- Check43 days agoChange DetectedThe Study Record Dates now display Revision: v3.5.3, replacing the previous v3.5.2, signaling a recent update to the study record. This update appears to be a version tag for record-keeping rather than a modification of the study content.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page revision identifier was updated from v3.5.0 to v3.5.2, with no visible changes to the study information content.SummaryDifference0.0%

Stay in the know with updates to Filgotinib Long-Term Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Long-Term Ulcerative Colitis Clinical Trial page.